Symphony Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,714
| Closed | -$1.21M | – | 145 |
|
|
2019
Q4 | $1.21M | Buy |
3,714
+168
| +5% | +$54.6K | 0.27% | 37 |
|
|
2019
Q3 | $1.03M | Sell |
3,546
-4
| -0.1% | -$1.17K | 0.22% | 49 |
|
|
2019
Q2 | $1.04M | Buy |
3,550
+524
| +17% | +$154K | 0.22% | 57 |
|
|
2019
Q1 | $828K | Buy |
3,026
+45
| +2% | +$12.3K | 0.21% | 70 |
|
|
2018
Q4 | $667K | Buy |
+2,981
| New | +$667K | 0.2% | 55 |
|
|
2018
Q3 | – | Sell |
-6,039
| Closed | -$1.25M | – | 281 |
|
|
2018
Q2 | $1.25M | Sell |
6,039
-136
| -2% | -$28.1K | 0.25% | 87 |
|
|
2018
Q1 | $1.28M | Sell |
6,175
-5,926
| -49% | -$1.22M | 0.16% | 143 |
|
|
2017
Q4 | $2.3M | Sell |
12,101
-9,332
| -44% | -$1.77M | 0.23% | 103 |
|
|
2017
Q3 | $4.06M | Buy |
21,433
+1,733
| +9% | +$328K | 0.45% | 53 |
|
|
2017
Q2 | $3.44M | Buy |
19,700
+4,759
| +32% | +$830K | 0.39% | 65 |
|
|
2017
Q1 | $2.3M | Buy |
14,941
+1,656
| +12% | +$254K | 0.22% | 112 |
|
|
2016
Q4 | $1.88M | Buy |
13,285
+2,869
| +28% | +$405K | 0.19% | 125 |
|
|
2016
Q3 | $1.66M | Buy |
+10,416
| New | +$1.66M | 0.17% | 141 |
|
|
2013
Q4 | – | Sell |
-7,747
| Closed | -$714K | – | 472 |
|
|
2013
Q3 | $714K | Buy |
7,747
+2,334
| +43% | +$215K | 0.07% | 243 |
|
|
2013
Q2 | $458K | Buy |
+5,413
| New | +$458K | 0.04% | 297 |
|